海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
2336件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Study Evaluating the Efficacy and Safety of Bapineuzumab in Alzheimer Disease Patients Who Are Apolipoprotein E e4 Carriers
- Alzheimer Disease MedDRA version: 14.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Austria, Belgium, Chile, Croatia, Denmark, Finland, France, Germany, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Poland, Portugal, Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, United Kingdom, United States
- 2008-02-22
Not Recruiting
- Ensayo de fase III, multicéntrico, aleatorizado, en doble ciego, controlado con placebo y de grupos paralelos, sobre la eficacia y la seguridad del bapineuzumab (AAB-001, ELN115727) en pacientes con enfermedad de Alzheimer de grado leve a moderado que no son portadores de la apolipoproteína E (ApoE) e4 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E e4 Non-carriers
- Enfermedad de Alzheimer Alzheimer Disease MedDRA version: 9.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type ;Enfermedad de Alzheimer Alzheimer Disease MedDRA version: 9.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type
- Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Portugal, Slovakia, Spain, Sweden, United Kingdom
- 2008-02-25
Not Recruiting
- UKALL XI (92) - Acute lymphoblastic leukaemia trial
- Leukaemia Cancer Acute lymphoblastic leukaemia
- United Kingdom
- 2000-10-25
Not Recruiting
- A 54-week, double-blind, randomized, placebo-controlled, parallel-group study to investigate the effects of rosiglitazone (extended release tablets) as adjunctive therapy to donepezil on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease (REFLECT-2) - REFLECT-2
- Alzheimers Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease ;Alzheimers Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease
- Austria, Czech Republic, Germany, Greece, Hungary, Italy, Portugal, Spain
- 2006-07-20
Authorised
- A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1)
- Mild to Moderate Alzheimer's Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease
- Austria, Bulgaria, Estonia, Germany, Greece, Hungary, United Kingdom
- 2006-11-23
Recruiting
- Bewegen, niet vergeten!
- EN: Alzheimer's Disease, Inactivity, ApoE-e4, genetic vulnerability for Alzheimer's Disease NL: ziekte van Alzheimer, dementie, inactiviteit, ApoE-e4 dragerschap, genetische kwetsbaarheid voor Alzheimer
- The Netherlands
- 2016-06-29
Not Recruiting
- A 54-week, double-blind, randomized, placebo-controlled, parallel-group study to investigate the effects of rosiglitazone (extended release tablets) as adjunctive therapy to acetylcholinesterase inhibitors on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease (REFLECT-3)
- Alzheimer's Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease ;Alzheimer's Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease
- Belgium, Czech Republic, Finland, Germany, Netherlands, Spain, Sweden, United Kingdom
- 2006-07-05
Not recruiting
- "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
- Contraception;Liver Metabolism;Hemostasis Parameter
- Netherlands
- 2016-10-25
Not recruiting
- Adherence to PTH(1-84) Treatment (FP-002-IM)
- Clinical Use of PTH(1-84);Clinical Use of PTH(1-84);Clinical Use of PTH(1-84);Clinical Use of PTH(1-84)
- Denmark, Germany
- 2007-05-23
Not recruiting
- Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
- Alzheimer's Disease
- Austria, Canada, Germany, United States
- 2007-12-10